Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/20952513

Download in:

View as

General Info

PMID
20952513